Gliclazide-induced acute hepatitis with hypersensitivity features

Digestive Diseases and Sciences

Volumn 47, Issue 5, 2002, Pages 1107-1110

  Chitturi, Shivakumar ^a   Le, Vu ^a   Kench, James ^a   Loh, Christopher ^a   George, Jacob ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Drug induced hepatitis; Gliclazide; Hepatitis; Hypersensitivity; Sulfonylurea

Indexed keywords

ANTIHISTAMINIC AGENT; FEXOFENADINE; GLICLAZIDE; METFORMIN;

ACUTE HEPATITIS; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIVER TOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

ACUTE DISEASE; ADULT; FEMALE; GLICLAZIDE; HEPATITIS, TOXIC; HUMANS; HYPERSENSITIVITY; HYPOGLYCEMIC AGENTS;

EID: 0036232447     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015002526879     Document Type: Article

References (15)

1. Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus
2. Gliclazide-induced hepatitis
3. Glyburide-induced hepatitis
4. Intrahepatic cholestasis and cutaneous bullae assoeiated with glibenclamide therapy
5. Glibenclamide-induced cholestasis
6. Generalized hypersensitivity reaction and visceral arteritis with fatal outcome during glibenclamide therapy
7. Eosinophilic pleural effusion due to gliclazide
8. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis
9. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study
10. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying liver disease
11. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
12. Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment
13. Metformin treatment in patients with nonalcoholic steatohepatitis normalizes LFTs and improves histology
14. Drug-induced cholestasis: Pathogenesis and clinical features